Annual FCF
-$13.96 M
-$1.19 M-9.34%
December 1, 2023
Summary
- As of February 10, 2025, SKYE annual free cash flow is -$13.96 million, with the most recent change of -$1.19 million (-9.34%) on December 1, 2023.
- During the last 3 years, SKYE annual FCF has fallen by -$7.90 million (-130.39%).
- SKYE annual FCF is now -735084.21% below its all-time high of $1900.00, reached on October 1, 2012.
Performance
SKYE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$6.78 M
+$344.90 K+4.84%
September 1, 2024
Summary
- As of February 10, 2025, SKYE quarterly free cash flow is -$6.78 million, with the most recent change of +$344.90 thousand (+4.84%) on September 1, 2024.
- Over the past year, SKYE quarterly FCF has dropped by -$2.07 million (-43.93%).
- SKYE quarterly FCF is now -82796.34% below its all-time high of $8200.00, reached on July 1, 2013.
Performance
SKYE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$22.47 M
-$2.72 M-13.79%
September 1, 2024
Summary
- As of February 10, 2025, SKYE TTM free cash flow is -$22.47 million, with the most recent change of -$2.72 million (-13.79%) on September 1, 2024.
- Over the past year, SKYE TTM FCF has dropped by -$7.86 million (-53.77%).
- SKYE TTM FCF is now -1604907.14% below its all-time high of -$1400.00, reached on April 1, 2014.
Performance
SKYE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SKYE Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.3% | -43.9% | -53.8% |
| 3 y3 years | -130.4% | -228.1% | -126.7% |
| 5 y5 years | -253.8% | -228.1% | -126.7% |
SKYE Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -112.7% | at low | -240.4% | +4.8% | -242.2% | at low |
| 5 y | 5-year | -131.7% | at low | -559.6% | +4.8% | -325.1% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +4.8% | <-9999.0% | at low |
Skye Bioscience Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.78 M(-4.8%) | -$22.47 M(+13.8%) |
| Jun 2024 | - | -$7.13 M(+51.3%) | -$19.75 M(+35.1%) |
| Mar 2024 | - | -$4.71 M(+22.3%) | -$14.61 M(+4.6%) |
| Dec 2023 | -$13.96 M(+9.3%) | -$3.85 M(-5.1%) | -$13.96 M(-6.9%) |
| Sep 2023 | - | -$4.06 M(+103.8%) | -$15.00 M(+15.3%) |
| Jun 2023 | - | -$1.99 M(-51.0%) | -$13.01 M(-6.6%) |
| Mar 2023 | - | -$4.06 M(-16.8%) | -$13.92 M(+9.0%) |
| Dec 2022 | -$12.77 M(+94.5%) | -$4.88 M(+136.3%) | -$12.77 M(+28.9%) |
| Sep 2022 | - | -$2.07 M(-28.8%) | -$9.91 M(+5.9%) |
| Jun 2022 | - | -$2.90 M(-0.4%) | -$9.36 M(+15.2%) |
| Mar 2022 | - | -$2.92 M(+44.2%) | -$8.12 M(+23.7%) |
| Dec 2021 | -$6.57 M(+8.3%) | -$2.02 M(+33.7%) | -$6.57 M(+3.7%) |
| Sep 2021 | - | -$1.51 M(-9.4%) | -$6.33 M(-6.8%) |
| Jun 2021 | - | -$1.67 M(+23.0%) | -$6.79 M(+10.5%) |
| Mar 2021 | - | -$1.36 M(-23.9%) | -$6.15 M(+1.5%) |
| Dec 2020 | -$6.06 M(+0.6%) | -$1.79 M(-9.5%) | -$6.05 M(+4.9%) |
| Sep 2020 | - | -$1.97 M(+92.0%) | -$5.77 M(+9.2%) |
| Jun 2020 | - | -$1.03 M(-18.8%) | -$5.29 M(-9.8%) |
| Mar 2020 | - | -$1.27 M(-15.8%) | -$5.86 M(-2.7%) |
| Dec 2019 | -$6.03 M(+52.7%) | -$1.50 M(+1.0%) | -$6.03 M(+8.8%) |
| Sep 2019 | - | -$1.49 M(-7.3%) | -$5.54 M(+13.8%) |
| Jun 2019 | - | -$1.61 M(+12.2%) | -$4.87 M(+12.5%) |
| Mar 2019 | - | -$1.43 M(+41.1%) | -$4.32 M(+9.5%) |
| Dec 2018 | -$3.95 M | -$1.01 M(+24.2%) | -$3.95 M(-22.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$816.30 K(-23.2%) | -$5.08 M(+16.4%) |
| Jun 2018 | - | -$1.06 M(+0.8%) | -$4.36 M(+22.2%) |
| Mar 2018 | - | -$1.05 M(-50.8%) | -$3.57 M(+7.1%) |
| Dec 2017 | -$3.35 M(-6.0%) | -$2.14 M(+2043.5%) | -$3.33 M(+80.0%) |
| Sep 2017 | - | -$100.00 K(-63.2%) | -$1.85 M(-18.2%) |
| Jun 2017 | - | -$271.40 K(-66.8%) | -$2.26 M(-29.8%) |
| Mar 2017 | - | -$816.40 K(+23.2%) | -$3.22 M(-9.6%) |
| Dec 2016 | -$3.56 M(-4.4%) | -$662.80 K(+29.5%) | -$3.56 M(-11.2%) |
| Sep 2016 | - | -$511.70 K(-58.4%) | -$4.01 M(-16.4%) |
| Jun 2016 | - | -$1.23 M(+6.1%) | -$4.80 M(+16.0%) |
| Mar 2016 | - | -$1.16 M(+4.1%) | -$4.14 M(+10.9%) |
| Dec 2015 | -$3.73 M(+109.7%) | -$1.11 M(-14.1%) | -$3.73 M(+42.6%) |
| Sep 2015 | - | -$1.30 M(+128.4%) | -$2.62 M(+98.3%) |
| Jun 2015 | - | -$567.70 K(-24.5%) | -$1.32 M(+62.6%) |
| Mar 2015 | - | -$751.70 K(+1154.9%) | -$811.60 K(+1067.8%) |
| Dec 2014 | -$1.78 M(+2696.4%) | - | - |
| Jul 2014 | - | -$59.90 K(-1915.2%) | -$69.50 K(+4864.3%) |
| Apr 2014 | - | $3300.00(-180.5%) | -$1400.00(-82.1%) |
| Jan 2014 | - | -$4100.00(-53.4%) | -$7800.00(-87.8%) |
| Oct 2013 | -$63.60 K(-3447.4%) | -$8800.00(-207.3%) | -$63.70 K(+16.0%) |
| Jul 2013 | - | $8200.00(-364.5%) | -$54.90 K(-13.0%) |
| Apr 2013 | - | -$3100.00(-94.8%) | -$63.10 K(+5.2%) |
| Jan 2013 | - | -$60.00 K | -$60.00 K |
| Oct 2012 | $1900.00 | - | - |
FAQ
- What is Skye Bioscience annual free cash flow?
- What is the all time high annual FCF for Skye Bioscience?
- What is Skye Bioscience annual FCF year-on-year change?
- What is Skye Bioscience quarterly free cash flow?
- What is the all time high quarterly FCF for Skye Bioscience?
- What is Skye Bioscience quarterly FCF year-on-year change?
- What is Skye Bioscience TTM free cash flow?
- What is the all time high TTM FCF for Skye Bioscience?
- What is Skye Bioscience TTM FCF year-on-year change?
What is Skye Bioscience annual free cash flow?
The current annual FCF of SKYE is -$13.96 M
What is the all time high annual FCF for Skye Bioscience?
Skye Bioscience all-time high annual free cash flow is $1900.00
What is Skye Bioscience annual FCF year-on-year change?
Over the past year, SKYE annual free cash flow has changed by -$1.19 M (-9.34%)
What is Skye Bioscience quarterly free cash flow?
The current quarterly FCF of SKYE is -$6.78 M
What is the all time high quarterly FCF for Skye Bioscience?
Skye Bioscience all-time high quarterly free cash flow is $8200.00
What is Skye Bioscience quarterly FCF year-on-year change?
Over the past year, SKYE quarterly free cash flow has changed by -$2.07 M (-43.93%)
What is Skye Bioscience TTM free cash flow?
The current TTM FCF of SKYE is -$22.47 M
What is the all time high TTM FCF for Skye Bioscience?
Skye Bioscience all-time high TTM free cash flow is -$1400.00
What is Skye Bioscience TTM FCF year-on-year change?
Over the past year, SKYE TTM free cash flow has changed by -$7.86 M (-53.77%)